InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Explore the detailed record of transactions filed by Segal Jeffrey, Director. Director active across 1 company, notably INVO Bioscience, Inc.. In total, 2 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €8k. Activity tracked since 15 January 2022. The latest transaction was disclosed on 1 June 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Segal Jeffrey
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
9,211 shares@ US$0.95100.0% of flowCommon StockSEC:0001493152-22-015908:0
Canonical exit: 30 Aug 2022 (T+90)
8,034 shares0Common StockSEC:0001493152-22-001534:0
2 of 2 declarations
About Segal Jeffrey
Jeffrey Segal is a Director at INVO Bioscience, Inc. As a board member, he contributes to the governance and strategy of the company. His experience in the biotechnology sector allows him to provide valuable insights into the development of new treatments.
